TY - JOUR
T1 - When neonatal inflammation does not mean infection
T2 - an early-onset mevalonate kinase deficiency with interstitial lung disease
AU - Pietrasanta, Carlo
AU - Minoia, Francesca
AU - Torreggiani, Sofia
AU - Ronchi, Andrea
AU - Gattorno, Marco
AU - Volpi, Stefano
AU - Ceccherini, Isabella
AU - Mosca, Fabio
AU - Filocamo, Giovanni
AU - Pugni, Lorenza
N1 - Copyright © 2019 Elsevier Inc. All rights reserved.
PY - 2019/8
Y1 - 2019/8
N2 - Systemic inflammation in neonates is attributable to an infection in almost all cases. When inflammation persists, an autoinflammatory disease should be promptly suspected. We report here a case of mevalonate kinase deficiency (MKD) that presented at birth with mild symptoms and signs suggestive for a perinatal infection, together with the uncommon finding of interstitial lung disease. An extensive diagnostic work-up, performed after ineffective antibiotic treatment, demonstrated high levels of mevalonic acid in urine (7024 mM/M of creatinine, normal value <0.1). Next-generation sequencing showed a rare c.709A > T (p.T237S) homozygous mutation in the MVK gene, consistent with MKD. Treatment with anakinra led to a prompt resolution of symptoms and a sharp drop in serum inflammatory markers. The patient is now six months-old, currently undergoing evaluation for hematopoietic stem-cell transplantation. To our knowledge, this is the first case of MKD presenting within the first week of life with interstitial lung disease.
AB - Systemic inflammation in neonates is attributable to an infection in almost all cases. When inflammation persists, an autoinflammatory disease should be promptly suspected. We report here a case of mevalonate kinase deficiency (MKD) that presented at birth with mild symptoms and signs suggestive for a perinatal infection, together with the uncommon finding of interstitial lung disease. An extensive diagnostic work-up, performed after ineffective antibiotic treatment, demonstrated high levels of mevalonic acid in urine (7024 mM/M of creatinine, normal value <0.1). Next-generation sequencing showed a rare c.709A > T (p.T237S) homozygous mutation in the MVK gene, consistent with MKD. Treatment with anakinra led to a prompt resolution of symptoms and a sharp drop in serum inflammatory markers. The patient is now six months-old, currently undergoing evaluation for hematopoietic stem-cell transplantation. To our knowledge, this is the first case of MKD presenting within the first week of life with interstitial lung disease.
U2 - 10.1016/j.clim.2019.05.002
DO - 10.1016/j.clim.2019.05.002
M3 - Article
C2 - 31096039
SN - 1521-6616
VL - 205
SP - 25
EP - 28
JO - Clinical Immunology
JF - Clinical Immunology
ER -